BRAVADA International Ltd. (
) (Pink Sheets:BRAV) announced today that it has no plans to issue any new common stock for capital considerations as long as it perceives its stock price to be undervalued. The Company has made this determination from a number of criteria. First and foremost is that free cash-flow from operations continues to increase and significant growth can be derived from this alone as demonstrated in its fiscal year 2012 where the Company experienced 250% revenue growth and yet did not issue even one share of its common stock in 2012.
The other consideration for not diluting its common stock is from a pure evaluation metric. The Company believes that given its valuation, growth rate, margins and forward-looking value, a sales multiple of 8-12 times can be argued easily and that any dilution significantly below the Company’s evaluation and growth potential would harm the Company and shareholders. Fiscal year 2012 revenue was $3,476,066.50, and the Company believes that fiscal year 2013 could see the same kind of growth rate (250%) as 2012. With a current market capitalization of just over one (1) times 2012 revenue and one-half (0.5) 2013 revenue, it would be irresponsible to issue common stock for capital at this evaluation. Shareholders should expect that most, if not all, profits will go to growing BRAVADA International whether it is to increase our retail store footprint or growing online sales, profits will be reinvested into growth.
“We are and always will make determinations that make sense for shareholders to ensure maximum value is achieved in our common stock,” replied Danny Alex, CEO of BRAVADA International. “To issue common stock for capital at a market capitalization that we feel significantly undervalues the Company harms all shareholders. New investors must acquire a position, big or small, from the open market as the Company will not issue new common stock for capital at these evaluations.”